Our data strongly suggest that ZNF420 and ZNF496 are both involved in KIRC progression as tumor suppressors, as their upregulation corresponds to better patient survival and lower tumor grade followed by a significant depletion of cancer stemness characteristics. Here, ZNF420 is linked to cancer.